Encouraging findings suggest new avenues for treating liver disease in overweight Americans
2010-10-19
(Press-News.org) San Antonio, Texas, October 18, 2010 – Estimates of the prevalence of liver disease suggest that one‐third of the United States population has non‐alcoholic fatty liver disease (NAFLD). NAFLD is now the most common cause for elevated liver function tests in the United States, a trend related to the obesity epidemic in this country. Non‐alcoholic steatohepatitis (NASH), the progressive form of NAFLD, can lead to cirrhosis and all its complications. Two studies presented at the 75th Annual Scientific Meeting of the American College of Gastroenterology investigated the effectiveness of potential treatments for NASH, one assessing pentoxifylline, a well‐known drug with a well‐established safety profile that inhibits the release of TNFα among other mechanisms; as well as a separate analysis of pioglitazone, an insulin sensitizer, compared to vitamin E.
Pentoxifyline Improves Progressive Liver Disease NASH Compared to Placebo
Claudia O. Zein, M.D. and colleagues at the Cleveland Veterans Affairs Medical Center and the Cleveland Clinic in Cleveland, OH conducted a double‐blinded, randomized, placebo‐controlled trial of pentoxifylline in patients with NASH to assess improvement in levels of transaminases and improvement in histological features of NASH as measured by the NAFLD activity score (NAS). The NAS score measures disease activity and is derived from the sum of separate scores for fat, inflammation, and ballooning in the liver.
The study, "Pentoxifyline Improves Non‐Alcoholic Steatohepatitis: Results of a Double‐Blinded, Randomized, Placebo‐Controlled Trial," found that after one year, an improvement of 30 percent or more in ALT levels from baseline was observed in a significantly higher proportion of subjects taking pentoxifylline compared to those on placebo (p=0.02). Additionally, a decrease of greater than 2 points in the NAS score was seen in half the pentoxifylline group versus 16 percent of those on placebo (p=0.01). Pentoxifylline significantly improved steatosis (fat in the liver) and inflammation, but no significant changes in ballooning were observed. A trend suggesting lack of progression of fibrosis (scar tissue in the liver) was also noted in the pentoxifylline group compared to placebo.
"There is a need for effective treatments for NASH. Previous experimental and pilot data suggesting potential benefits of pentoxifylline in NASH encouraged us to conduct this randomized, placebo controlled trial," explained Dr. Zein.
"The higher frequency of biochemical and histological improvement observed in our study among patients who received pentoxifylline compared to placebo, suggest both a reason for hope and a need for further studies," added Dr. Zein. She advises that physicians should suspect and investigate for fatty liver disease among patients who are at high risk, including those who are overweight, diabetic, or have other elements of the metabolic syndrome. "General recommendations in the management of patients with fatty liver disease include weight reduction for obese patients, and optimized management of the components of the metabolic syndrome, if present. However, there is still a need for effective medical therapeutic agents for NASH, and that is why the results of this study are so encouraging," Dr. Zein concluded.
Indiana Study Explores Changes in Adipose Tissue Insulin Resistance in NASH
Although insulin sensitizers have been the main focus for developing new treatments for NASH, the study by Dr. Zein and another study by the NIDDK‐funded NASH Clinical Research Network (NASH CRN) presented at the ACG Annual Scientific meeting in San Antonio as a late breaking abstract indicate that pathways other than insulin resistance could be used for developing effective treatments for NASH.
The investigators from the NASH CRN have recently published a paper in The New England Journal of Medicine showing significant efficacy for vitamin E (800 I.U./day) in improving liver histology in patients with NASH. In a study presented at the 2010 ACG Meeting, "Changes in Adipose Tissue Insulin Resistance Correlate with Changes in Liver Histology in NASH Patients who Participated in the PIVENS Trial," Lauren Bell, Ph.D. and colleagues from Indiana University School of Medicine have investigated whether changes in insulin resistance are responsible for the improvement in liver histology seen with vitamin E.
Non‐diabetic adult patients with NASH were randomized to receive pioglitazone (a drug used in Type 2 diabetes), vitamin E, or placebo and followed after 96 weeks of treatment. Vitamin E showed statistically significant improvement in hepatic histology whereas the response to pioglitazone was favorable, but did not reach the pre‐specified p‐value < 0.025. At baseline and at 96 weeks, investigators measured an index of adipose tissue insulin resistance (Adipo‐IR).
"Although Adipo‐IR was not different from placebo in either treatment group after 96 weeks, there were trends for improvement with pioglitazone and worsening of Adipo‐IR with vitamin E, suggesting that the positive effect of vitamin E on liver histology is independent of changes in adipose tissue insulin resistance," explained Dr. Bell. The mechanism by which vitamin E improves liver histology remains unknown but it is thought to be due to its intrahepatic antioxidant effects. Dr. Bell's finding that increases in Adipo‐IR correlated with worsening fibrosis, if confirmed, could be an important non‐invasive test for monitoring liver fibrosis in patients with NASH.
INFORMATION:
About the American College of Gastroenterology
Founded in 1932, the American College of Gastroenterology (ACG) is an organization with an international membership of more than 11,000 individuals from 80 countries. The College is committed to serving the clinically oriented digestive disease specialist through its emphasis on scholarly practice, teaching and research. The mission of the College is to serve the evolving needs of physicians in the delivery of high quality, scientifically sound, humanistic, ethical, and cost‐effective health care to gastroenterology patients. www.acg.gi.org View releases on other research breaking at the ACG meeting at www.acg.gi.org/media/press.asp
ELSE PRESS RELEASES FROM THIS DATE:
New studies highlight obesity's impact on gastrointestinal health
2010-10-19
San Antonio, Texas (October 18, 2010) – The association between obesity and gastrointestinal-related cancers and coronary artery disease; the link between an overweight or obese body mass index and the severity of Crohn's disease; and whether inflammatory bowel disease is an independent risk factor for coronary artery disease, were among the highlights of new research that was presented this week at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio.
Obesity Linked to Increased Liver Cancer Risk, Adenoma Recurrence
Although ...
Investment in CRC screening targeting pre-medicare population could cut medicare treatment costs
2010-10-19
San Antonio, Texas (October 18, 2010) – Investment in screening programs that target the pre-Medicare population, individuals aged between 50 and 64, is needed to reduce the costs of colorectal cancer in the Medicare program, according to the results of a new study, "Cost-Savings to Medicare from Increased Colorectal Cancer Screening in the Pre-Medicare Population," unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.
"With rising chemotherapy costs and aging of the population, the Medicare program will ...
National Stroke Association survey reveals more than half of stroke survivors suffer added burden of little known neurologic condition
2010-10-19
CENTENNIAL, CO – October 18, 2010 – A survey released today by National Stroke Association shows that 53 percent of stroke survivor respondents suffer from symptoms of another neurologic condition called pseudobulbar affect (PBA), a condition thought to be caused by structural damage in the brain due to injury or disease. PBA causes involuntary and unpredictable outbursts of laughing or crying, often in socially inappropriate situations. Even though a significant proportion of stroke survivors suffer from PBA, fewer than one in five are familiar with the condition.
Survey ...
Colonoscopy technique increases polyp detection in far reaches of right colon
2010-10-19
San Antonio, Texas, October 18, 2010 – Research exploring the progression of colon polyps to colorectal cancer and evaluating techniques to improve polyp detection was among the clinical science presented at the 75th Annual Scientific Meeting of the American College of Gastroenterology in San Antonio today.
The Progression to Colorectal Cancer in Flat Polyps
Precancerous growths in the colon known as sessile serrated adenomas (SSA) are found in approximately 1 percent of colonoscopy exams. A sessile serrated ademona is a premalignant flat lesion in the colon thought ...
100-million-year-old mistake provides snapshot of evolution
2010-10-19
Research by University of Leeds plant scientists has uncovered a snapshot of evolution in progress, by tracing how a gene mutation over 100 million years ago led flowers to make male and female parts in different ways.
The findings – published this week in the Proceedings of the National Academy of Sciences (PNAS) Online Early Edition – provide a perfect example of how diversity stems from such genetic 'mistakes'. The research also opens the door to further investigation into how plants make flowers – the origins of the seeds and fruits that we eat.
In a number of plants, ...
When vertebrae cross dress: How sloths got their long neck
2010-10-19
By examining the development of bones in the vertebral column, limbs, and ribcage, scientists at the University of Cambridge have discovered how sloths evolved their unique neck skeleton.
From mice to giraffes, mammals are remarkable in that all but a handful of their 5000 species have exactly seven vertebrae in the neck. Among the few that deviate from this number are three-toed sloths, which may have up to ten ribless vertebrae in the neck.
Traditionally, vertebrae above the shoulders that lack ribs are known as cervical or neck vertebrae. Animals such as birds and ...
Removing 2mm around breast cancer tumors prevents residual disease in 98 percent of patients
2010-10-19
Removing an extra two millimetres around an area of invasive breast cancer is sufficient to minimise any residual disease in 98 per cent of patients, according to research published in the November issue of IJCP, the International Journal of Clinical Practice.
Surgeons from the Department of Breast Surgery at Good Hope Hospital, Sutton Coldfield, UK, studied 303 women who had undergone breast conserving surgery at the hospital between 2002 and 2008.
"Breast conserving surgery followed by radiotherapy is a well-established alternative to breast removal and studies have ...
Drivel on Facebook more valuable than we think
2010-10-19
Superficial contacts on Facebook, apparently unnecessary comments, and banal status updates may be more worthwhile than we think. This is shown in a new report from the National IT User Center. The report also predicts the new social media will ultimately lead to more individual entrepreneurs.
Many people are critical of those who collect hundreds of so-called friends on Facebook. Often the majority of these "friends" are old classmates, acquaintances of acquaintances, and the like, relationships that are fundamentally weak. The comments and updates of relatively banal ...
A mystery solved: How genes are selectively silenced
2010-10-19
Our genetic material is often compared to a book. However, it is not so much like a novel to be read in one piece, but rather like a cookbook. The cell reads only those recipes which are to be cooked at the moment. The recipes are the genes; 'reading' in the book of the cell means creating RNA copies of individual genes, which will then be translated into proteins.
The cell uses highly complex, sophisticated regulatory mechanisms to make sure that not all genes are read at the same time. Particular gene switches need to be activated and, in addition, there are particular ...
Body's bacteria affect atherosclerosis
2010-10-19
New findings suggesting that bacteria in the mouth and/or intestine can affect the the outcome pathogenesis of atherosclerosis and lead to new treatment strategies, reveals research from the University of Gothenburg, Sweden.
The results are to be published in the distinguished journal Proceedings of the National Academy of Sciences, PNAS.
"The causes of atherosclerosis have recently become clearer, but we know less about why the plaque in the arteries ruptures and contributes to clot formation," says Fredrik Bäckhed, researcher at the Sahlgrenska Academy's Department ...